Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Gregory Schwartz

Concepts (589)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Acute Coronary Syndrome
74
2025
297
15.780
 Why?
Anticholesteremic Agents
55
2026
155
12.490
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
57
2025
444
7.650
 Why?
Lipoprotein(a)
22
2025
69
7.370
 Why?
Antibodies, Monoclonal, Humanized
47
2025
992
6.360
 Why?
Cholesterol, LDL
53
2026
360
6.300
 Why?
Myocardial Infarction
45
2026
1211
4.750
 Why?
Cardiovascular Diseases
41
2026
2191
4.320
 Why?
Proprotein Convertase 9
29
2025
87
3.690
 Why?
Coronary Disease
16
2020
382
3.010
 Why?
Angina, Unstable
19
2019
83
2.720
 Why?
Heptanoic Acids
23
2016
67
2.560
 Why?
Cholesterol, HDL
13
2020
201
2.550
 Why?
Diabetes Mellitus, Type 2
23
2025
2602
2.490
 Why?
Dyslipidemias
9
2025
184
2.420
 Why?
Sulfhydryl Compounds
10
2020
189
2.420
 Why?
Hypercholesterolemia
11
2023
95
2.380
 Why?
Pyrroles
23
2016
220
2.360
 Why?
Stroke
32
2026
1271
2.230
 Why?
Quinazolinones
7
2021
18
2.080
 Why?
Serine Proteinase Inhibitors
6
2025
48
2.080
 Why?
Atherosclerosis
12
2026
409
1.580
 Why?
Myocardial Ischemia
17
2018
285
1.550
 Why?
Thiazolidinediones
10
2017
143
1.520
 Why?
Secondary Prevention
11
2019
251
1.510
 Why?
Double-Blind Method
43
2025
2064
1.490
 Why?
Cholesterol
12
2022
408
1.490
 Why?
Treatment Outcome
68
2026
11794
1.410
 Why?
Oxazoles
9
2022
48
1.350
 Why?
Esters
9
2020
71
1.340
 Why?
Amides
9
2020
101
1.320
 Why?
Thiophenes
9
2022
117
1.280
 Why?
Cholesterol Ester Transfer Proteins
5
2016
22
1.270
 Why?
Hypoglycemic Agents
18
2024
1399
1.210
 Why?
Risk Factors
45
2024
10919
1.200
 Why?
Aged
83
2026
26217
1.190
 Why?
Myocardial Contraction
14
2013
293
1.130
 Why?
Ventricular Fibrillation
3
2017
64
1.120
 Why?
Middle Aged
87
2026
36309
1.110
 Why?
Humans
176
2026
145783
1.110
 Why?
Swine
35
2023
826
1.090
 Why?
Coronary Artery Disease
6
2023
750
1.070
 Why?
Risk Assessment
21
2025
3752
1.060
 Why?
C-Reactive Protein
11
2022
423
1.060
 Why?
Insulin Resistance
10
2018
1244
1.050
 Why?
Antibodies, Monoclonal
7
2023
1505
1.000
 Why?
Myocardium
23
2004
935
1.000
 Why?
Diabetic Angiopathies
2
2019
267
0.990
 Why?
Metabolic Syndrome
4
2013
361
0.980
 Why?
Male
110
2026
73011
0.970
 Why?
Female
116
2026
79045
0.910
 Why?
Myocardial Reperfusion Injury
5
2013
139
0.900
 Why?
Ischemic Attack, Transient
6
2018
71
0.890
 Why?
Heart
10
2009
626
0.860
 Why?
Lipoproteins, HDL
4
2019
100
0.850
 Why?
PPAR gamma
6
2022
182
0.840
 Why?
Proteins
3
2020
1023
0.840
 Why?
RNA, Small Interfering
11
2026
638
0.830
 Why?
Hyperlipoproteinemia Type II
4
2026
32
0.820
 Why?
Proprotein Convertases
2
2014
16
0.810
 Why?
Peripheral Arterial Disease
3
2020
509
0.800
 Why?
Triglycerides
5
2024
520
0.760
 Why?
Biomarkers
24
2025
4302
0.760
 Why?
Fatty Acids, Nonesterified
4
2018
154
0.690
 Why?
Randomized Controlled Trials as Topic
19
2024
1752
0.690
 Why?
Renal Insufficiency, Chronic
6
2026
668
0.690
 Why?
Time Factors
22
2025
7134
0.670
 Why?
Patient Admission
2
2021
220
0.660
 Why?
Insulin
7
2021
2516
0.660
 Why?
Coronary Circulation
18
2004
134
0.650
 Why?
Cardiovascular Agents
4
2021
166
0.630
 Why?
Molecular Targeted Therapy
2
2014
441
0.630
 Why?
Hospitalization
5
2019
2461
0.610
 Why?
Recurrence
11
2021
1139
0.600
 Why?
Energy Metabolism
13
2004
935
0.560
 Why?
Adiponectin
2
2018
242
0.550
 Why?
Swine, Miniature
3
2013
89
0.550
 Why?
Lipid Metabolism
2
2014
529
0.530
 Why?
Venous Thrombosis
1
2020
196
0.530
 Why?
Brain Ischemia
5
2022
359
0.530
 Why?
Ezetimibe
4
2023
24
0.520
 Why?
Heart Arrest
4
2017
411
0.520
 Why?
Aldosterone
1
2017
42
0.500
 Why?
Rosuvastatin Calcium
4
2022
21
0.490
 Why?
Cardiovascular System
1
2018
139
0.480
 Why?
Venous Thromboembolism
1
2020
328
0.450
 Why?
Phospholipids
4
2025
214
0.440
 Why?
Arteriosclerosis
2
2014
83
0.440
 Why?
Patient Readmission
2
2021
773
0.430
 Why?
Drug Therapy, Combination
6
2020
1043
0.420
 Why?
Adenosine Triphosphate
14
2017
500
0.410
 Why?
Magnetic Resonance Spectroscopy
17
2019
627
0.390
 Why?
Metformin
1
2017
329
0.390
 Why?
Diabetes Complications
3
2021
225
0.390
 Why?
Apolipoproteins
4
2025
38
0.390
 Why?
Heart Failure
10
2026
2326
0.380
 Why?
Animals
49
2023
38102
0.380
 Why?
Phosphocreatine
13
1995
44
0.370
 Why?
Phosphates
7
2024
177
0.370
 Why?
Ventricular Function, Left
9
2004
544
0.360
 Why?
Blood Pressure
11
2012
1782
0.360
 Why?
Hemodynamics
11
2007
1118
0.360
 Why?
Veterans
3
2023
1642
0.360
 Why?
Proportional Hazards Models
9
2019
1330
0.350
 Why?
Coronary Vessels
8
2012
246
0.350
 Why?
Obesity
3
2024
3118
0.340
 Why?
Uncertainty
1
2012
146
0.340
 Why?
Dietary Fats
2
2013
308
0.340
 Why?
Atrial Fibrillation
2
2022
558
0.330
 Why?
Drug Administration Schedule
8
2019
782
0.330
 Why?
Glucose
5
2020
1049
0.320
 Why?
Follow-Up Studies
11
2023
5428
0.320
 Why?
Systole
7
2001
181
0.320
 Why?
Fluorobenzenes
2
2014
17
0.320
 Why?
Reperfusion Injury
2
2005
292
0.310
 Why?
Research Design
3
2009
1139
0.310
 Why?
Risk
9
2018
923
0.300
 Why?
Phospholipases A2, Secretory
4
2014
14
0.300
 Why?
Diastole
5
2001
146
0.290
 Why?
Ischemia
1
2012
422
0.280
 Why?
Ventricular Dysfunction, Right
3
2007
248
0.280
 Why?
Surgical Procedures, Operative
4
2017
271
0.270
 Why?
Apolipoproteins B
5
2022
47
0.270
 Why?
KATP Channels
1
2008
23
0.270
 Why?
Cohort Studies
6
2023
6033
0.260
 Why?
Clinical Trials, Phase III as Topic
3
2024
116
0.260
 Why?
Chromans
3
2004
25
0.260
 Why?
Acute Disease
9
2012
1036
0.260
 Why?
Hypolipidemic Agents
3
2022
89
0.260
 Why?
Peptide Fragments
4
2024
697
0.260
 Why?
Dose-Response Relationship, Drug
7
2019
2028
0.250
 Why?
Survival Analysis
7
2018
1378
0.250
 Why?
Mortality
3
2017
381
0.250
 Why?
Incidence
7
2022
2934
0.250
 Why?
Veterans Health
2
2020
190
0.250
 Why?
Apolipoprotein B-100
2
2025
13
0.250
 Why?
Potassium
2
2014
152
0.250
 Why?
Sodium
2
2020
198
0.240
 Why?
Cholecalciferol
1
2007
61
0.240
 Why?
Diet
3
2025
1278
0.240
 Why?
Pyrimidines
2
2014
530
0.240
 Why?
Prognosis
6
2024
4330
0.240
 Why?
Sulfonamides
2
2014
583
0.230
 Why?
Subtilisins
2
2023
9
0.230
 Why?
Hyperlipoproteinemia Type III
1
2025
4
0.230
 Why?
Fenofibrate
1
2005
28
0.230
 Why?
Endpoint Determination
1
2026
85
0.230
 Why?
Phenylurea Compounds
1
2026
119
0.220
 Why?
Dobutamine
5
2000
24
0.220
 Why?
Acetates
3
2019
78
0.220
 Why?
Adrenergic beta-Antagonists
3
2013
252
0.220
 Why?
Oxygen Consumption
8
2000
719
0.220
 Why?
Quinolines
1
2026
190
0.220
 Why?
Myelodysplastic Syndromes
1
2007
165
0.210
 Why?
Apolipoprotein A-I
2
2018
39
0.210
 Why?
Disease Models, Animal
8
2013
4568
0.210
 Why?
Cardiotonic Agents
3
2005
94
0.210
 Why?
Blood Glucose
6
2024
2344
0.210
 Why?
Natriuretic Peptide, Brain
3
2024
109
0.210
 Why?
Prediabetic State
2
2020
250
0.210
 Why?
Predictive Value of Tests
6
2025
2123
0.210
 Why?
Lanthanum
1
2024
13
0.210
 Why?
Morbidity
5
2017
322
0.210
 Why?
Hyperemia
3
1991
49
0.200
 Why?
Syndrome
6
2007
381
0.200
 Why?
Cause of Death
5
2017
472
0.200
 Why?
Injections, Subcutaneous
2
2024
170
0.200
 Why?
Phosphorylation
3
2013
1708
0.190
 Why?
Thiazoles
2
2003
142
0.190
 Why?
Isoproterenol
3
1998
96
0.190
 Why?
Serine Endopeptidases
2
2014
129
0.190
 Why?
Blood Vessels
1
2024
167
0.190
 Why?
Peroxisome Proliferator-Activated Receptors
4
2017
17
0.190
 Why?
Clinical Trials, Phase II as Topic
2
2019
75
0.190
 Why?
Genes, Bacterial
1
2023
152
0.180
 Why?
Residence Characteristics
3
2016
375
0.180
 Why?
Carcinoma, Hepatocellular
1
2026
373
0.180
 Why?
Lipids
3
2024
707
0.180
 Why?
Calcitriol
2
2003
58
0.180
 Why?
Multicenter Studies as Topic
3
2019
413
0.180
 Why?
Prostatic Neoplasms
5
2003
981
0.180
 Why?
Calcifediol
2
2000
31
0.180
 Why?
Livestock
2
2023
9
0.170
 Why?
Insulin Receptor Substrate Proteins
2
2013
55
0.170
 Why?
Receptors, Cytoplasmic and Nuclear
1
2003
209
0.170
 Why?
Diacetyl
1
2001
7
0.170
 Why?
Indoles
3
2019
507
0.170
 Why?
PPAR alpha
4
2022
55
0.170
 Why?
Propensity Score
2
2021
377
0.170
 Why?
Muscles
1
2022
330
0.170
 Why?
Cost-Benefit Analysis
2
2020
644
0.170
 Why?
Artificial Intelligence
1
2026
381
0.170
 Why?
Mental Status and Dementia Tests
1
2021
27
0.160
 Why?
Cytokines
2
2005
2069
0.160
 Why?
Oxidative Stress
2
2025
1360
0.160
 Why?
Pancreatic Neoplasms
2
2000
928
0.160
 Why?
Myocardial Reperfusion
1
2000
56
0.160
 Why?
Cataract
1
2023
238
0.160
 Why?
Glucagon-Like Peptide-1 Receptor
1
2020
88
0.150
 Why?
Calpain
2
2012
61
0.150
 Why?
Lipoproteins, LDL
2
2014
119
0.150
 Why?
Coronary Artery Bypass
2
2019
268
0.150
 Why?
Matrix Metalloproteinases
1
2000
95
0.150
 Why?
Cadmium
1
2000
68
0.150
 Why?
Liver Neoplasms
1
2026
777
0.150
 Why?
Non-alcoholic Fatty Liver Disease
1
2022
265
0.150
 Why?
Oncogenes
1
2000
118
0.150
 Why?
Perioperative Care
2
2017
231
0.150
 Why?
Renin-Angiotensin System
1
2019
80
0.140
 Why?
Proto-Oncogene Proteins c-akt
2
2013
440
0.140
 Why?
Alkaline Phosphatase
1
2019
144
0.140
 Why?
Aged, 80 and over
9
2026
8347
0.140
 Why?
Adrenergic beta-Agonists
1
1998
92
0.140
 Why?
Adenylyl Cyclases
2
2016
60
0.140
 Why?
Early Termination of Clinical Trials
2
2015
18
0.140
 Why?
Immunoturbidimetry
1
2018
1
0.140
 Why?
Carotid Artery Diseases
1
2018
70
0.140
 Why?
United States
7
2023
16126
0.140
 Why?
Risk Reduction Behavior
1
2020
217
0.140
 Why?
Multifactorial Inheritance
1
2019
209
0.130
 Why?
Collagen
1
2000
457
0.130
 Why?
American Heart Association
1
2019
358
0.130
 Why?
Environment
2
2016
293
0.130
 Why?
Citrate (si)-Synthase
1
2017
57
0.130
 Why?
Prostate
1
1998
159
0.120
 Why?
Microalgae
1
2016
8
0.120
 Why?
Pharmacogenetics
2
2016
175
0.120
 Why?
Ponds
1
2016
16
0.120
 Why?
Transcription Factors
2
2016
1736
0.120
 Why?
Hypertension, Pulmonary
3
2012
1957
0.120
 Why?
Australia
4
2019
291
0.120
 Why?
Administration, Intravenous
1
2017
172
0.120
 Why?
Waste Disposal, Fluid
1
2016
52
0.120
 Why?
HIV Long Terminal Repeat
1
2016
12
0.120
 Why?
Global Health
2
2017
403
0.120
 Why?
Drug Design
1
2017
175
0.120
 Why?
Percutaneous Coronary Intervention
2
2019
549
0.120
 Why?
tat Gene Products, Human Immunodeficiency Virus
1
2016
25
0.120
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2026
1969
0.120
 Why?
Inflammation Mediators
2
2013
507
0.120
 Why?
Simvastatin
2
2015
59
0.120
 Why?
HIV Envelope Protein gp120
1
2016
55
0.120
 Why?
Lipoproteins
2
2014
166
0.120
 Why?
Adult
15
2026
40881
0.120
 Why?
Inflammation
6
2016
2884
0.120
 Why?
Signal Transduction
1
2009
5224
0.120
 Why?
Epigenesis, Genetic
1
2021
693
0.120
 Why?
AMP-Activated Protein Kinases
1
2017
192
0.110
 Why?
Bacteria
2
2023
766
0.110
 Why?
Clinical Trials as Topic
2
2018
1062
0.110
 Why?
Heart Ventricles
6
2012
756
0.110
 Why?
Postoperative Complications
2
2019
2977
0.110
 Why?
Glomerular Filtration Rate
3
2026
765
0.110
 Why?
Anti-Arrhythmia Agents
2
2012
144
0.110
 Why?
ATP Binding Cassette Transporter 1
1
2015
13
0.110
 Why?
Platelet Aggregation Inhibitors
1
2019
499
0.110
 Why?
Vasodilation
2
2013
521
0.110
 Why?
Recombinant Proteins
1
2018
1368
0.110
 Why?
Chromosomes, Human, Pair 16
1
2015
36
0.110
 Why?
Smoking
2
2000
1477
0.110
 Why?
Hospital Mortality
1
2019
1038
0.110
 Why?
Wireless Technology
1
2014
18
0.110
 Why?
Linkage Disequilibrium
1
2015
255
0.100
 Why?
Homeostasis
1
2018
644
0.100
 Why?
Transistors, Electronic
1
2014
4
0.100
 Why?
Serum Amyloid A Protein
3
2013
32
0.100
 Why?
Stents
1
2018
564
0.100
 Why?
Seawater
1
2014
33
0.100
 Why?
Heart Rate
5
2001
856
0.100
 Why?
Ions
1
2014
66
0.100
 Why?
Disease Progression
4
2018
2865
0.100
 Why?
Fresh Water
1
2014
53
0.100
 Why?
Phospholipases A
1
2014
97
0.100
 Why?
Metals, Heavy
1
2014
31
0.100
 Why?
Fasting
1
2015
279
0.100
 Why?
Mendelian Randomization Analysis
1
2013
58
0.100
 Why?
Commerce
1
2014
80
0.100
 Why?
Endovascular Procedures
1
2018
390
0.100
 Why?
Acyl Coenzyme A
1
2013
32
0.100
 Why?
Heart Function Tests
1
2013
59
0.090
 Why?
Ultraviolet Rays
2
1992
385
0.090
 Why?
Hydroxy Acids
1
2012
4
0.090
 Why?
Ventricular Function, Right
1
1995
297
0.090
 Why?
Monitoring, Physiologic
1
2014
289
0.090
 Why?
Talin
1
2012
9
0.090
 Why?
Ischemic Preconditioning, Myocardial
1
2012
35
0.090
 Why?
Decanoic Acids
1
2012
12
0.090
 Why?
Glyburide
1
2012
31
0.090
 Why?
Cardiolipins
1
2013
82
0.090
 Why?
Nitric Oxide Synthase Type III
1
2013
203
0.090
 Why?
Potassium Channel Blockers
1
2012
47
0.090
 Why?
Polymorphism, Genetic
1
2015
615
0.090
 Why?
North America
3
2019
304
0.090
 Why?
1-Alkyl-2-acetylglycerophosphocholine Esterase
1
2012
24
0.090
 Why?
Biosensing Techniques
1
2014
142
0.090
 Why?
Case-Control Studies
1
2019
3634
0.090
 Why?
Europe
3
2019
421
0.090
 Why?
Retrospective Studies
6
2018
17330
0.090
 Why?
DNA
2
2013
1437
0.090
 Why?
Keto Acids
3
2019
10
0.080
 Why?
Oxidation-Reduction
4
2025
1069
0.080
 Why?
Practice Guidelines as Topic
1
2019
1582
0.080
 Why?
Hypertension
1
2000
1276
0.080
 Why?
Arteries
1
2013
261
0.080
 Why?
Prospective Studies
2
2021
8078
0.080
 Why?
Tissue Plasminogen Activator
2
2013
248
0.080
 Why?
Genetic Variation
1
2016
977
0.080
 Why?
MAP Kinase Signaling System
1
2013
308
0.080
 Why?
Manure
2
2023
7
0.080
 Why?
Fractures, Bone
1
2016
428
0.080
 Why?
Prejudice
1
2011
60
0.080
 Why?
Myocardial Revascularization
3
2017
85
0.080
 Why?
Electrocardiography
3
2011
668
0.080
 Why?
Death, Sudden, Cardiac
1
2012
237
0.080
 Why?
Phosphorus
5
1995
90
0.080
 Why?
Down-Regulation
2
2024
618
0.080
 Why?
Gene Expression Regulation
2
2013
2601
0.080
 Why?
HIV-1
1
2016
908
0.080
 Why?
United States Department of Veterans Affairs
3
2016
779
0.080
 Why?
Polymers
1
2014
485
0.080
 Why?
RNA, Messenger
3
2015
2805
0.070
 Why?
Age Factors
3
2011
3346
0.070
 Why?
MicroRNAs
1
2015
686
0.070
 Why?
Critical Care
1
2014
702
0.070
 Why?
Macrophages
1
2016
1507
0.070
 Why?
Vitamin D Deficiency
1
1990
190
0.070
 Why?
Vascular Diseases
2
2022
252
0.070
 Why?
Feeding Behavior
1
2014
692
0.070
 Why?
Ventricular Pressure
1
2007
52
0.070
 Why?
Neoplasms
1
2023
2913
0.070
 Why?
Equipment Design
3
2014
525
0.070
 Why?
Diabetes Mellitus
1
2016
1101
0.060
 Why?
Phosphatidylinositol 3-Kinases
1
2009
383
0.060
 Why?
Vitamin D
3
2000
404
0.060
 Why?
Models, Biological
1
2014
1764
0.060
 Why?
Angiomatosis
1
2006
5
0.060
 Why?
Ultrasonography, Interventional
2
2018
166
0.060
 Why?
Hemangioma, Capillary
1
2006
14
0.060
 Why?
Kaplan-Meier Estimate
2
2020
971
0.060
 Why?
Reactive Oxygen Species
1
2009
611
0.060
 Why?
Survival Rate
1
2011
2094
0.060
 Why?
Lactic Acid
2
1998
295
0.060
 Why?
Anti-Inflammatory Agents
1
2009
478
0.060
 Why?
Angina Pectoris
2
2004
76
0.060
 Why?
Ultrasonography
1
2009
788
0.060
 Why?
Cerebrovascular Disorders
2
2017
105
0.060
 Why?
Apolipoproteins E
1
2025
93
0.060
 Why?
Liver
2
2024
1899
0.050
 Why?
Chronic Disease
1
2011
1812
0.050
 Why?
alpha-Tocopherol
1
2004
32
0.050
 Why?
Sus scrofa
1
2004
65
0.050
 Why?
Pulse Wave Analysis
1
2025
267
0.050
 Why?
Vegetables
1
2025
162
0.050
 Why?
Linear Models
2
2013
849
0.050
 Why?
Heterozygote
1
2025
314
0.050
 Why?
Antigen-Antibody Complex
1
2004
69
0.050
 Why?
Arterial Occlusive Diseases
2
1982
90
0.050
 Why?
CD40 Ligand
1
2004
40
0.050
 Why?
Least-Squares Analysis
1
2004
73
0.050
 Why?
Administration, Oral
1
2007
867
0.050
 Why?
Economics, Pharmaceutical
1
2003
10
0.050
 Why?
Muscular Diseases
1
2004
109
0.050
 Why?
Ergocalciferols
1
2003
14
0.050
 Why?
Tumor Cells, Cultured
3
2003
887
0.050
 Why?
Radiation-Sensitizing Agents
1
2003
43
0.050
 Why?
Regional Blood Flow
3
1996
514
0.050
 Why?
Comorbidity
2
2019
1662
0.050
 Why?
Guidelines as Topic
1
2005
268
0.050
 Why?
Lactates
2
1994
82
0.050
 Why?
beta-Lactams
1
2023
32
0.050
 Why?
Death
2
2019
132
0.050
 Why?
Angiotensin Receptor Antagonists
1
2023
115
0.040
 Why?
Creatine Kinase
1
2022
72
0.040
 Why?
Soil Microbiology
1
2023
115
0.040
 Why?
Pharmacogenomic Testing
1
2022
63
0.040
 Why?
Multivariate Analysis
2
2017
1547
0.040
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2023
229
0.040
 Why?
Drug Resistance, Bacterial
1
2023
185
0.040
 Why?
Verapamil
1
2001
37
0.040
 Why?
Precision Medicine
1
2025
461
0.040
 Why?
Organ Preservation Solutions
1
2001
46
0.040
 Why?
Antioxidants
1
2004
550
0.040
 Why?
Receptors, Immunologic
1
2022
209
0.040
 Why?
Controlled Clinical Trials as Topic
1
2000
27
0.040
 Why?
Goals
1
2022
185
0.040
 Why?
Ventricular Dysfunction
1
2000
16
0.040
 Why?
Myocardial Stunning
1
2000
4
0.040
 Why?
Tissue Inhibitor of Metalloproteinases
1
2000
16
0.040
 Why?
Collagenases
1
2000
22
0.040
 Why?
Hexamethonium
1
2000
5
0.040
 Why?
Vascular Stiffness
1
2025
487
0.040
 Why?
Liver Cirrhosis
1
2022
288
0.040
 Why?
Atropine
1
2000
37
0.040
 Why?
Dilatation, Pathologic
1
2000
61
0.040
 Why?
Arrhythmias, Cardiac
1
2003
356
0.040
 Why?
Louisiana
1
2000
31
0.040
 Why?
Interleukin-6
3
2013
780
0.040
 Why?
Health Care Costs
1
2003
425
0.040
 Why?
Dipeptides
2
2012
56
0.040
 Why?
Cell Line
2
2016
2823
0.040
 Why?
Occupations
1
2000
51
0.040
 Why?
Placebo Effect
1
2019
24
0.040
 Why?
Matrix Metalloproteinase 9
1
2000
131
0.040
 Why?
Pericardium
1
2000
59
0.040
 Why?
Ventricular Dysfunction, Left
1
2003
394
0.040
 Why?
Pilot Projects
1
2025
1898
0.040
 Why?
Blood Chemical Analysis
1
2020
109
0.040
 Why?
Phospholipase A2 Inhibitors
1
2019
3
0.040
 Why?
New Zealand
1
2019
55
0.040
 Why?
Insulin Antagonists
1
1998
6
0.040
 Why?
Ventricular Function
1
1999
53
0.040
 Why?
Logistic Models
1
2004
2139
0.040
 Why?
Antigens, CD
1
2022
558
0.040
 Why?
Hormone Antagonists
1
1998
33
0.040
 Why?
Hungary
1
2018
4
0.040
 Why?
Placebos
1
2019
193
0.040
 Why?
Somatostatin
1
1998
53
0.040
 Why?
Israel
1
2018
46
0.040
 Why?
Infusion Pumps
1
2018
33
0.040
 Why?
Pulmonary Artery
2
2006
1129
0.040
 Why?
Microscopy, Electron
1
1999
414
0.030
 Why?
India
1
2019
213
0.030
 Why?
Netherlands
1
2018
84
0.030
 Why?
Drug Combinations
1
2000
396
0.030
 Why?
Elasticity
1
1999
189
0.030
 Why?
Sex Characteristics
1
2024
789
0.030
 Why?
Florida
1
1998
117
0.030
 Why?
Protective Factors
1
2018
99
0.030
 Why?
Drug Interactions
1
2019
405
0.030
 Why?
Sex Factors
1
2024
2110
0.030
 Why?
Algorithms
1
2026
1851
0.030
 Why?
Blood Flow Velocity
1
1999
421
0.030
 Why?
Drug Industry
1
2017
49
0.030
 Why?
Selection Bias
1
2017
38
0.030
 Why?
Catheterization
1
1997
184
0.030
 Why?
Poverty Areas
1
2016
43
0.030
 Why?
Echocardiography, Transesophageal
1
1997
132
0.030
 Why?
Drug Evaluation, Preclinical
1
2017
196
0.030
 Why?
Chi-Square Distribution
1
2017
528
0.030
 Why?
Urban Health
1
2016
96
0.030
 Why?
Erythrocytes
1
2022
749
0.030
 Why?
Pharmacogenomic Variants
1
2016
35
0.030
 Why?
Rural Health
1
2016
87
0.030
 Why?
Drug Discovery
1
2017
153
0.030
 Why?
Cardiac Catheterization
1
2000
559
0.030
 Why?
Internationality
1
2017
156
0.030
 Why?
Viral Tropism
1
2016
36
0.030
 Why?
Receptors, CCR5
1
2016
60
0.030
 Why?
Albuminuria
1
2017
189
0.030
 Why?
Receptors, CXCR4
1
2016
91
0.030
 Why?
Immunoglobulin M
2
2009
265
0.030
 Why?
CD4 Antigens
1
2016
137
0.030
 Why?
Troponin
2
2007
50
0.030
 Why?
Membrane Proteins
1
2022
1166
0.030
 Why?
Attitude of Health Personnel
1
2004
1197
0.030
 Why?
Fatty Acids
1
1998
457
0.030
 Why?
Body Mass Index
1
2024
2447
0.030
 Why?
Genome-Wide Association Study
1
2022
1430
0.030
 Why?
Myalgia
1
2015
13
0.030
 Why?
Angioplasty, Balloon, Coronary
1
1996
156
0.030
 Why?
Creatinine
1
2017
515
0.030
 Why?
Receptors, LDL
1
2015
53
0.030
 Why?
Physicians
1
2004
956
0.030
 Why?
Electromagnetic Radiation
1
2014
3
0.030
 Why?
Thrombolytic Therapy
1
1996
164
0.030
 Why?
Carotid Intima-Media Thickness
1
2015
75
0.030
 Why?
Cognitive Dysfunction
1
2021
468
0.030
 Why?
Social Class
1
2016
264
0.030
 Why?
Myositis
1
2015
57
0.030
 Why?
Chemotherapy, Adjuvant
1
1996
427
0.030
 Why?
Lidocaine
1
1994
55
0.030
 Why?
Quality of Life
1
2007
3211
0.030
 Why?
Fat Emulsions, Intravenous
1
1994
29
0.030
 Why?
Hypertrophy, Left Ventricular
1
1995
124
0.030
 Why?
Adenosine
2
1994
255
0.030
 Why?
Calibration
1
2014
152
0.030
 Why?
Analysis of Variance
1
2017
1300
0.030
 Why?
ATP-Binding Cassette Transporters
1
2015
117
0.030
 Why?
Electric Stimulation
1
1995
277
0.030
 Why?
Osmolar Concentration
1
1994
168
0.030
 Why?
Seasons
1
2016
538
0.030
 Why?
Semiconductors
1
2014
27
0.030
 Why?
Adenosine Diphosphate
1
1994
83
0.030
 Why?
Stroke Volume
1
1997
655
0.020
 Why?
Gene Expression Regulation, Neoplastic
1
2000
1450
0.020
 Why?
Pressure
1
2014
226
0.020
 Why?
Mice
3
2016
18356
0.020
 Why?
NAD
1
1994
79
0.020
 Why?
Solutions
1
2014
159
0.020
 Why?
Patient Outcome Assessment
1
2014
130
0.020
 Why?
Glycine
1
1994
186
0.020
 Why?
Perioperative Period
1
2013
71
0.020
 Why?
Hyperglycemia
1
2017
380
0.020
 Why?
Vascular Cell Adhesion Molecule-1
1
2013
42
0.020
 Why?
Mitochondria, Heart
1
1994
107
0.020
 Why?
Materials Testing
1
2014
345
0.020
 Why?
Binding Sites
1
2016
1311
0.020
 Why?
Heparin
1
1994
247
0.020
 Why?
Oxidative Phosphorylation
1
1994
209
0.020
 Why?
Dose-Response Relationship, Radiation
1
1992
141
0.020
 Why?
Immunoglobulin G
2
2009
892
0.020
 Why?
Nutrition Surveys
1
2014
279
0.020
 Why?
Actinin
1
2012
12
0.020
 Why?
Dogs
3
1984
478
0.020
 Why?
Socioeconomic Factors
1
2016
1327
0.020
 Why?
Weight Gain
1
2016
561
0.020
 Why?
Anti-Bacterial Agents
1
2023
1925
0.020
 Why?
Mathematics
1
1992
101
0.020
 Why?
Cardiomyopathy, Dilated
2
1992
356
0.020
 Why?
Cardiac Output, Low
1
1992
53
0.020
 Why?
South Africa
1
2013
266
0.020
 Why?
Electrophoresis, Polyacrylamide Gel
1
2012
331
0.020
 Why?
Vascular Resistance
2
1984
370
0.020
 Why?
Patient Selection
1
1996
739
0.020
 Why?
Biopsy
1
1995
1082
0.020
 Why?
Reperfusion
1
1991
54
0.020
 Why?
Perfusion
1
1992
251
0.020
 Why?
Disease-Free Survival
1
2013
770
0.020
 Why?
Georgia
1
2011
79
0.020
 Why?
Poisson Distribution
1
2011
78
0.020
 Why?
Constriction
1
1990
45
0.020
 Why?
Vitamin D-Binding Protein
1
1990
16
0.020
 Why?
Cross-Sectional Studies
2
2014
5925
0.020
 Why?
Cells, Cultured
1
1998
4151
0.020
 Why?
Anticoagulants
1
1996
748
0.020
 Why?
Regression Analysis
1
1992
1001
0.020
 Why?
Alleles
1
2013
896
0.020
 Why?
Patient Discharge
1
2017
995
0.020
 Why?
Cell Division
2
2003
757
0.020
 Why?
Hypoglycemia
1
2015
480
0.020
 Why?
Cognition Disorders
1
2014
544
0.020
 Why?
Autoantibodies
2
2009
1509
0.020
 Why?
Polymorphism, Single Nucleotide
1
2016
2181
0.020
 Why?
Fibrin Fibrinogen Degradation Products
1
2009
92
0.020
 Why?
Educational Status
1
2011
470
0.020
 Why?
Young Adult
2
2016
14254
0.020
 Why?
Thromboembolism
1
2009
129
0.020
 Why?
Environmental Exposure
1
1992
578
0.020
 Why?
Spectrin
1
2007
14
0.020
 Why?
Desmin
1
2007
24
0.020
 Why?
Densitometry
1
2007
36
0.020
 Why?
Sarcoplasmic Reticulum Calcium-Transporting ATPases
1
2007
32
0.020
 Why?
Databases, Factual
1
2013
1491
0.020
 Why?
Poverty
1
2011
529
0.020
 Why?
Heart Diseases
1
1990
341
0.020
 Why?
Calcium-Binding Proteins
1
2007
221
0.010
 Why?
Kidney
1
2014
1497
0.010
 Why?
ROC Curve
1
2007
618
0.010
 Why?
Fatal Outcome
1
2006
305
0.010
 Why?
Protein Processing, Post-Translational
1
2007
473
0.010
 Why?
Aminophylline
1
1984
12
0.010
 Why?
Vasomotor System
1
1984
47
0.010
 Why?
Solubility
1
2004
240
0.010
 Why?
Mice, Inbred C57BL
1
2014
5993
0.010
 Why?
Radiation, Ionizing
1
2003
86
0.010
 Why?
DNA, Neoplasm
1
2003
160
0.010
 Why?
Health Care Surveys
1
2004
536
0.010
 Why?
Immunohistochemistry
1
2006
1723
0.010
 Why?
Odds Ratio
1
2004
1083
0.010
 Why?
Electrophysiology
1
1982
218
0.010
 Why?
Echocardiography
2
1997
648
0.010
 Why?
Blotting, Western
1
2003
1184
0.010
 Why?
Vascular Surgical Procedures
1
2004
343
0.010
 Why?
Mixed Function Oxygenases
1
2000
43
0.010
 Why?
Chemoprevention
1
2000
92
0.010
 Why?
Hydrogen-Ion Concentration
2
1991
532
0.010
 Why?
Adolescent
2
2016
22577
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2000
979
0.010
 Why?
Thorax
1
1997
51
0.010
 Why?
Phosphorus Isotopes
1
1995
8
0.010
 Why?
Infusions, Parenteral
1
1994
48
0.010
 Why?
Apoptosis
1
2003
2444
0.010
 Why?
Cardiac Pacing, Artificial
1
1995
84
0.010
 Why?
Basal Metabolism
1
1994
59
0.010
 Why?
Substrate Specificity
1
1995
387
0.010
 Why?
T-Lymphocytes
1
2002
1998
0.010
 Why?
Glycolysis
1
1995
340
0.010
 Why?
Lung
1
2006
4116
0.010
 Why?
Stimulation, Chemical
1
1992
52
0.010
 Why?
Rats, Sprague-Dawley
1
1997
2525
0.010
 Why?
Diphosphoglyceric Acids
1
1991
3
0.010
 Why?
2,3-Diphosphoglycerate
1
1991
32
0.010
 Why?
Radio Waves
1
1991
28
0.010
 Why?
Rats
1
1997
5585
0.000
 Why?
Cardiomegaly
1
1990
174
0.000
 Why?
Theophylline
1
1984
41
0.000
 Why?
Heart Block
1
1984
41
0.000
 Why?
Oxygen
1
1984
981
0.000
 Why?
Magnetic Resonance Imaging
1
1990
3916
0.000
 Why?
Schwartz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (589) concept(s)
_
Co-Authors Expand Description
See all (25) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)